Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosis.

Junya KitaharaShinji KakiharaTakao HiranoYoshiaki TakahashiAkira ImaiTeruyoshi MiyaharaToshinori Murata

Published in: Japanese journal of ophthalmology (2022)

µLOT for secondary glaucoma in ATTRv is safe and effective 1 year after surgery, but the effects diminish after 2 years.

Keyphrases